In the US, Cisplatin (cisplatin systemic) is a member of the drug class alkylating agents and is used to treat Bladder Cancer, Blood Cell Transplantation, Bone Marrow Transplantation, Brain Tumor, Cervical Cancer, Neuroblastoma, Non-Small Cell Lung Cancer, Osteogenic Sarcoma, Ovarian Cancer and Testicular Cancer.
US matches:
- Cisplatin
- Cisplatin Intravenous
UK matches:
- Cisplatin 1 mg/ml Sterile Concentrate (SPC)
- Cisplatin 50mg Freeze Dried Powder for Injection (SPC)
- Cisplatin BP 0.5mg/ml Sterile Concentrate (SPC)
- Cisplatin BP 1.0 mg/ml Sterile Concentrate (SPC)
Ingredient matches for Cisplatin
Cisplatin
Cisplatin (BAN, JAN, USAN) is known as Cisplatin in the US.
Colestipol
Colestipol hydrochloride (a derivative of Colestipol) is reported as an ingredient of Cisplatin in the following countries:
- United Kingdom
International Drug Name Search
Glossary
| BAN | British Approved Name |
| JAN | Japanese Accepted Name |
| SPC | Summary of Product Characteristics (UK) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment